Pay in 4 interest-free payments of $5.83 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
The 24.2% weight reduction at 48 weeks, combined with improvements in triglycerides, liver enzymes, and insulin sensitivity markers, positions Retatrutide as the more mechanistically complete compound in the Retatrutide vs Tirzepatide framework, pending Phase 3 confirmation
It helped control these patients glycemic numbers AND helped them lose weight
These details matter because insulin is measured in
Once the patent expires, other companies can produce generic versions, which drives down the cost
Published in 2009, Tschp and DiMarchi's results provided the first demonstration that dual agonist drugs had potential to induce weight loss (Day, Ottaway, Patterson)
Call if you have any questions
US$ 21.30
US$ 26.86
US$ 26.65
US$ 27.73
US$ 26.39
US$ 26.59
US$ 25.42
